Topic: Clinical trial specifically for advanced cholangiocarcinoma
Just wanted to share this piece of information...There is a clinical trial about to open at Wake Forest that is geared specifically toward cholangiocarcinoma! The agent is CP1-613, a novel chemotherapy agent that targets just the cancer cells. Has anyone heard of this drug? Everything I've read sounds promising; phrases like "strong anti-tumor activity" are being used to describe its effects.
My father is hanging in there; however, he was taken out of the clinical trial he was enrolled in at MUSC because his tumors grew more than 20%. We need a new plan...choice will be between a trial using ramucirumab with irinotecan and 5-FU (which sounds arduous; side effects of irinotecan sound tough) or the Wake Forest trial. Sure wish there was some way to know which would really give those tumors a swift kick...!